SCHEMBL810988

SCHEMBL810988

C1=C/CCC2OC2CC/C=C/CC/1

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.31
ALOX15 P16050 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10529141 1.00 ALDH1A1 (0.31) ALDH1A1ALOX15
SCHEMBL10529148 1.00 ALDH1A1 (0.31) ALDH1A1ALOX15
SCHEMBL4457806 1.00 ALDH1A1 (0.31) ALDH1A1ALOX15
SCHEMBL9355570 1.00 ALDH1A1 (0.31) ALDH1A1ALOX15
SCHEMBL3396734 1.00 ALDH1A1 (0.31) ALDH1A1ALOX15
SCHEMBL328857 1.00 ALDH1A1 (0.31) ALDH1A1ALOX15
SCHEMBL22614859 1.00 ALDH1A1 (0.31) ALDH1A1ALOX15
SCHEMBL22614858 1.00 ALDH1A1 (0.31) ALDH1A1ALOX15
SCHEMBL20617561 1.00 ALDH1A1 (0.31) ALDH1A1ALOX15
SCHEMBL3396728 1.00 ALDH1A1 (0.31) ALDH1A1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 730 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117623886-A Method for preparing CDON by catalytic hydrogenation and dehydrogenation of EPO or ECDA 万华化学集团股份有限公司 2024-03-01 CN claimed
US-20230233425-A1 USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR FIRMENICH SA (CH) 2023-07-27 US claimed
CN-110882724-B Platinum-supported catalyst, preparation method thereof and application thereof in cyclododecanol synthesis 万华化学集团股份有限公司 2022-11-08 CN claimed
CN-111234464-B Vacuum epoxy resin infusion system and preparation method and application thereof 万华化学集团股份有限公司 2022-07-12 CN claimed
CN-110746688-B Waterproof ventilated membrane 温州大学 2022-01-18 CN claimed
US-11203729-B2 Unsaturated macrocyclic epoxide as perfuming ingredient FIRMENICH SA (CH) 2021-12-21 US claimed
CN-110326866-B Convertible single double umbrella 浙江农林大学暨阳学院 2020-12-22 CN claimed
CN-111704633-A Mo catalyst and application thereof in preparation of 9, 10-epoxy-1, 5-cyclododecadiene 万华化学集团股份有限公司 2020-09-25 CN claimed
CN-111234464-A Vacuum epoxy resin infusion system and preparation method and application thereof 万华化学集团股份有限公司 2020-06-05 CN claimed
CN-110882724-A Platinum-supported catalyst, preparation method thereof and application thereof in cyclododecanol synthesis 万华化学集团股份有限公司 2020-03-17 CN claimed
EP-0897941-A1 CROSS-LINKED SOLID POLYELECTROLYTE AND USE THEREOF DAISO CO., LTD. (JP) 1999-02-24 EP claimed
EP-0885913-A1 COPOLYETHER AND SOLID POLYMER ELECTROLYTE DAISO CO., LTD. (JP) 1998-12-23 EP claimed
EP-0856538-A1 SOLID POLYELECTROLYTE DAISO CO., LTD. (JP) 1998-08-05 EP claimed
EP-0838487-A2 Polyether copolymer and polymer solid electrolyte DAISO CO., LTD. (JP) 1998-04-29 EP claimed
EP-0652706-A4 STORAGE-STABLE PESTICIDE COMPOSITIONS COMPRISING AZADIRACHTIN AND EPOXIDE. AGRIDYNE TECH INC (US) 1997-04-09 EP claimed
EP-0652706-A1 STORAGE-STABLE PESTICIDE COMPOSITIONS COMPRISING AZADIRACHTIN AND EPOXIDE AGRIDYNE TECHNOLOGIES, INC. (US) 1995-05-17 EP claimed
US-5352697-A Storage stable pesticide compositions comprising azadirachtin and epoxide AGRIDYNE TECHNOLOGIES, INC. (US) 1994-10-04 US claimed
WO-1994002019-A1 STORAGE-STABLE PESTICIDE COMPOSITIONS COMPRISING AZADIRACHTIN AND EPOXIDE AGRIDYNE TECHNOLOGIES, INC. (US) 1994-02-03 WO claimed
EP-0033763-B1 PROCESS FOR THE PREPARATION OF 1,2-EPOXY-5,9-CYCLODODECADIENE Degussa Aktiengesellschaft (DE) 1983-08-31 EP claimed
EP-0033763-A1 Process for the preparation of 1,2-epoxy-5,9-cyclododecadiene Degussa Aktiengesellschaft (DE) 1981-08-19 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11203729-B2 Unsaturated macrocyclic epoxide as perfuming ingredient PTGES, TECR, EPHX2 ALDH1A1 607/4885ALOX15 12/4885
US-20230233425-A1 USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR TAS2R8, TRPA1, TAS2R10 ALDH1A1 831/4885ALOX15 514/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.